esketamine
Articles tagged with “esketamine”
Treatment-Resistant Depression Algorithms: Where Ketamine Fits
Analysis of where ketamine fits within treatment-resistant depression algorithms, reviewing staging models, sequencing strategies, and evidence-based positioning in the TRD pathway.
Spravato (Esketamine) Nasal Spray Protocol and Administration Guidelines
A detailed clinical guide to the FDA-approved intranasal esketamine (Spravato) protocol, covering REMS program requirements, dosing schedules, administration procedures, and post-dose monitoring for treatment-resistant depression and major depressive disorder with suicidal ideation.
Research and Clinical Evidence
Questions and answers about the scientific evidence supporting ketamine therapy, FDA approval status, landmark clinical trials, and the direction of ongoing research.
Esketamine vs Racemic Ketamine Dosing: Comparative Pharmacology
Comparative pharmacology of esketamine versus racemic ketamine dosing, examining enantiomer-specific receptor binding, clinical potency differences, and dosing equivalencies.
IV Racemic Ketamine vs Esketamine (Spravato): A Clinical Comparison
Evidence-based comparison of IV racemic ketamine and intranasal esketamine (Spravato) for treatment-resistant depression, examining mechanism differences, efficacy data, FDA status, cost, access, and side effects.
Telehealth Ketamine Marketing Compliance: Regulatory and Ethical Guidelines
Regulatory guide for marketing at-home ketamine therapy and esketamine services, covering FDA rules, DEA requirements, and state telemedicine laws.
Cost-Effectiveness of Ketamine Therapy: Health Economic Evidence
Health economic analysis of ketamine therapy cost-effectiveness, examining direct treatment costs, comparative value versus alternatives, QALY gains, and payer perspectives.
Ready to learn more?
Explore our comprehensive guides and tools to help you navigate your ketamine therapy journey.